0001209191-20-050714.txt : 20200916 0001209191-20-050714.hdr.sgml : 20200916 20200916164635 ACCESSION NUMBER: 0001209191-20-050714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200914 FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERINS PATRICK J CENTRAL INDEX KEY: 0001235112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38129 FILM NUMBER: 201179291 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mersana Therapeutics, Inc. CENTRAL INDEX KEY: 0001442836 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-498-0020 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: MERSANA THERAPEUTICS INC DATE OF NAME CHANGE: 20080813 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-14 1 0001442836 Mersana Therapeutics, Inc. MRSN 0001235112 KERINS PATRICK J 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 Common Stock 2020-09-14 4 J 0 2000000 0.00 D 5959520 I See Note 2 Common Stock 2020-09-14 4 J 0 20000 0.00 A 20000 I See Note 4 Common Stock 2020-09-14 4 J 0 20000 0.00 D 0 I See Note 4 Common Stock 2020-09-14 4 J 0 10000 0.00 A 10000 I See Note 7 Common Stock 2020-09-14 4 J 0 10000 0.00 D 0 I See Note 7 Common Stock 2020-09-14 4 J 0 830 0.00 A 3222 D Common Stock 2020-09-14 4 J 0 372 0.00 A 3594 D New Enterprise Associates 14, L.P. ("NEA 14") made a pro rata distribution for no consideration of an aggregate of 2,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on September 14, 2020. The Reporting Person is a director of NEA 14 GP, LTD ("NEA 14 LTD"), which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of NEA 14, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest. NEA Partners 14 received 20,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on September 14, 2020. The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA Partners 14, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 14 shares in which the Reporting Person has no pecuniary interest. NEA Partners 14 made a pro rata distribution for no consideration of an aggregate of 20,000 shares of Common Stock of the Issuer to its limited partners on September 14, 2020. NEA 14 Manager Fund, L.P. ("NEA 14 Manager Fund") received 10,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on September 14, 2020. The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA 14 Manager Fund. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by NEA 14 Manager Fund in which the Reporting Person has no pecuniary interest. NEA 14 Manager Fund made a pro rata distribution for no consideration of an aggregate of 10,000 shares of Common Stock of the Issuer to its limited partners on September 14, 2020. The Reporting Person received 830 shares of Common Stock of the Issuer in the distribution by NEA Partners 14 on September 14, 2020. The Reporting Person received 372 shares of Common Stock of the Issuer in the distribution by NEA 14 Manager Fund on September 14, 2020. /s/ Sasha Keough, attorney-in-fact 2020-09-16